FTC Health Claim Substantiation for Dietary Supplements: What Taiwan Brands Must Prove

The Federal Trade Commission (FTC) has primary jurisdiction over advertising claims for dietary supplements in the United States, while the FDA regulates product labeling and safety. This dual-authority system means Taiwan brands selling supplements in the US must comply with both agencies, but it is the FTC that will take action against misleading or unsubstantiated claims made in advertising, social media, Amazon listings, website copy, and influencer content. The FTC Act Section 5 prohibits "unfair or deceptive acts or practices in or affecting commerce," and the FTC interprets any health-related claim about a supplement as a claim that requires substantiation before it is made.

The FTC's standard for substantiation is "competent and reliable scientific evidence," which the agency defines as "tests, analyses, research, studies, or other evidence based on the expertise of professionals in the relevant area, that has been conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results." In practice, this means published human clinical trials for specific health claims, not animal studies, in vitro studies, or traditional use evidence. The FTC has consistently rejected these alternative evidence types in enforcement actions against supplement companies.

Enforcement activity has intensified since 2023. The FTC filed or settled over 40 cases against dietary supplement companies in 2024 alone, with monetary penalties ranging from USD 100,000 to USD 12.8 million per case. The FTC targets claims about disease treatment or prevention, weight loss, cognitive enhancement, immune boosting, and anti-aging. Taiwan brands are not exempt from FTC jurisdiction: the FTC has taken action against foreign companies selling supplements in the US through Amazon and direct-to-consumer websites, and can enforce judgments by seizing US-based assets including Amazon seller account balances and bank accounts.

The practical implication for Taiwan brands is that every claim on your Amazon listing, website, social media, and advertising must be pre-vetted against the FTC's substantiation standard before publication. This includes claims in bullet points, A+ Content, product descriptions, customer-facing FAQ responses, and even implied claims made through images or testimonials. A product image showing a muscular person next to your supplement creates an implied claim about muscle building that the FTC will treat the same as a written claim. Establishing a claim review process before entering the US market is far cheaper than defending an FTC enforcement action after the fact.

The gold standard for FTC claim substantiation is one or more well-designed, randomized, double-blind, placebo-controlled human clinical trials published in peer-reviewed journals. The trial must test the specific product or the specific ingredient at the dosage used in the product, in a population relevant to the target consumer. A trial testing a different dosage, a different form of the ingredient, or a different population is insufficient. For example, if you sell a collagen peptide supplement at 5,000 mg per day claiming skin elasticity benefits, you need a trial testing collagen peptides at 5,000 mg per day measuring skin elasticity in human subjects, not a trial using 10,000 mg per day or measuring joint flexibility.

The FTC evaluates the totality of available evidence but gives the most weight to the most rigorous study designs. In descending order of evidentiary weight: systematic reviews and meta-analyses of randomized controlled trials, individual randomized controlled trials, non-randomized controlled trials, observational studies, and mechanistic studies. The FTC will not accept the sum of multiple weak studies as equivalent to one strong trial. If the best available evidence is two observational studies and a mechanistic study, the FTC will likely find the evidence insufficient for specific health claims. Taiwan brands should assess their ingredient evidence portfolio against this hierarchy before formulating marketing claims.

Structure-function claims, which describe the role of a nutrient in maintaining normal body structure or function (such as "calcium helps build strong bones"), face a lower FTC scrutiny threshold than disease claims (such as "prevents osteoporosis"). However, even structure-function claims require substantiation. The FTC has taken enforcement action against structure-function claims that lack adequate supporting evidence, particularly when the claims are made in a context that implies disease treatment. The line between a permissible structure-function claim and an impermissible disease claim is often ambiguous, and the FTC interprets the distinction strictly. Consult a US regulatory attorney experienced in FTC supplement enforcement to review your claims before market launch.

Testimonials and endorsements used in supplement advertising create specific substantiation obligations under the FTC's Endorsement Guides (revised October 2023). Consumer testimonials describing health benefits are treated as claims that must be substantiated and that represent the typical consumer experience. The FTC eliminated the "results not typical" disclaimer defense in 2023, meaning you cannot use exceptional testimonials with a disclaimer. Influencer content about your supplement is treated as advertising, and you are responsible for ensuring influencers do not make unsubstantiated health claims. Document clear written guidelines for all influencers and affiliates that specify exactly which claims are permitted and which are prohibited.

Create a substantiation binder for each product before launching in the US market. The binder should contain: a list of every claim made about the product in any advertising channel, the specific evidence supporting each claim (cited studies with full text copies), a summary written by a qualified expert explaining how the evidence supports the claim, and a record of the qualifications of the expert who reviewed the evidence. The FTC requires that substantiation be in place before a claim is made, not developed retroactively in response to an investigation. If the FTC requests your substantiation file through a civil investigative demand (CID), you must produce it within 20 to 30 days.

For Taiwan brands that manufacture proprietary formulations, investing in a clinical trial for your flagship product provides the strongest possible substantiation. A basic randomized controlled trial with 50 to 100 participants testing a single primary endpoint typically costs USD 150,000 to USD 500,000 and takes 12 to 18 months to complete. While this is a significant investment, it provides defensible evidence for marketing claims and creates a competitive advantage that competitors without clinical data cannot match. Conduct the trial at a US or internationally recognized research institution and publish the results in a peer-reviewed journal to maximize credibility with the FTC.

If a proprietary clinical trial is not feasible, build your evidence file using published research on your key ingredients. Search PubMed (pubmed.ncbi.nlm.nih.gov) for randomized controlled trials on each active ingredient at the dosage you use. Compile the relevant studies and have a qualified scientist (PhD or MD with relevant expertise) prepare an expert report summarizing the evidence and concluding whether the evidence supports each specific claim. The expert report should address the quality of the studies, the consistency of findings across studies, the relevance of the study populations to your target consumer, and any limitations or conflicting evidence. Budget USD 5,000 to USD 15,000 for a comprehensive expert evidence review.

Maintain your substantiation file as a living document. As new research is published, add relevant studies. As you modify claims in your advertising, add the updated claims and corresponding evidence. If you discover that evidence supporting a specific claim is weaker than initially assessed, modify the claim before the FTC identifies the issue. Annual evidence audits, where you review each active claim against current scientific literature, are a best practice that costs approximately USD 3,000 to USD 8,000 per year per product but dramatically reduces enforcement risk. The cost of maintaining substantiation is a fraction of the cost of an FTC settlement or litigation.

Amazon applies its own advertising policies on top of FTC requirements, and Amazon's policies are in some areas stricter than FTC standards. Amazon prohibits disease claims in all listing content, including titles, bullet points, descriptions, A+ Content, and backend search terms. Amazon's automated compliance scanning system flags listings containing prohibited terms such as "cure," "treat," "prevent," "diagnose," and over 100 additional restricted terms. Flagged listings are suppressed until the prohibited content is removed, which can take 3 to 14 days and results in lost sales and search ranking decay. Taiwan brands should run all listing content through Amazon's content compliance guidelines before publishing.

Common claim pitfalls for Taiwan supplement brands on Amazon include translating claims directly from Chinese-language marketing materials without considering US regulatory requirements. Claims that are legal in Taiwan, such as "improves immune function" or "promotes anti-aging," may violate both FTC substantiation standards and Amazon content policies in the US. The translation process must include a regulatory compliance review, not just a linguistic translation. Engage a US-based supplement regulatory consultant (USD 500 to USD 2,000 per product) to review your Amazon listing content before publication.

Customer Q&A sections on Amazon listings are another compliance risk area. When customers ask questions like "Will this supplement help with my arthritis?" and you respond with an affirmative answer, that response constitutes an advertising claim subject to FTC substantiation requirements. Train your customer service team to respond to health-related questions with factual information only, redirecting customers to consult their healthcare provider for specific medical advice. Never confirm or imply that your supplement treats, prevents, or cures any medical condition in customer communications.

Influencer and social media content promoting your Amazon supplements creates FTC liability for your brand. Under the 2023 Endorsement Guides, brands are responsible for monitoring and correcting unsubstantiated claims made by paid influencers, affiliates, and even some organic reviews that were solicited through free product programs. Establish a written influencer agreement that specifies approved claims language, requires FTC-required sponsorship disclosures, and gives your brand the right to require removal of non-compliant content. Monitor influencer content weekly and document your monitoring efforts, as the FTC considers active monitoring to be evidence of good faith compliance efforts.